Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study R Martínez-Fernández, R Rodríguez-Rojas, M Del Álamo, ... The Lancet Neurology 17 (1), 54-63, 2018 | 221 | 2018 |
Blood-brain barrier opening with focused ultrasound in Parkinson’s disease dementia C Gasca-Salas, B Fernández-Rodríguez, JA Pineda-Pardo, ... Nature communications 12 (1), 779, 2021 | 169 | 2021 |
Grey matter hypometabolism and atrophy in Parkinson’s disease with cognitive impairment: a two-step process R Gonzalez-Redondo, D García-García, P Clavero, C Gasca-Salas, ... Brain 137 (8), 2356-2367, 2014 | 157 | 2014 |
Actualización en la enfermedad de Parkinson R Martínez-Fernández, C Gasca-Salas, Á Sánchez-Ferro, JÁ Obeso Revista Médica Clínica Las Condes 27 (3), 363-379, 2016 | 155 | 2016 |
Randomized trial of focused ultrasound subthalamotomy for Parkinson’s disease R Martínez-Fernández, JU Máñez-Miró, R Rodríguez-Rojas, M Del Álamo, ... New England Journal of Medicine 383 (26), 2501-2513, 2020 | 147 | 2020 |
Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson’s disease D Garcia-Garcia, P Clavero, C Gasca Salas, I Lamet, J Arbizu, ... European journal of nuclear medicine and molecular imaging 39, 1767-1777, 2012 | 129 | 2012 |
The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: a cross-sectional multicenter study L Vela, JCM Castrillo, PG Ruiz, C Gasca-Salas, YM Macías, ... Journal of the neurological sciences 368, 150-154, 2016 | 102 | 2016 |
Parkinson's disease mild cognitive impairment: application and validation of the criteria GJ Geurtsen, J Hoogland, JG Goldman, BA Schmand, AI Tröster, DJ Burn, ... Journal of Parkinson's disease 4 (2), 131-137, 2014 | 82 | 2014 |
Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment C Gasca‐Salas, P Clavero, D García‐García, JA Obeso, ... Human brain mapping 37 (3), 968-977, 2016 | 61 | 2016 |
The long-term outcome of orthostatic tremor C Ganos, L Maugest, E Apartis, C Gasca-Salas, MT Cáceres-Redondo, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (2), 167-172, 2016 | 55 | 2016 |
Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease C Gasca-Salas, A Estanga, P Clavero, I Aguilar-Palacio, ... Journal of Parkinson's disease 4 (4), 677-686, 2014 | 55 | 2014 |
A phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease (PASADENA): rationale, design, and baseline data G Pagano, FG Boess, KI Taylor, B Ricci, B Mollenhauer, W Poewe, ... Frontiers in neurology 12, 705407, 2021 | 51 | 2021 |
Cortical disinhibition in Parkinson’s disease C Ammann, M Dileone, C Pagge, V Catanzaro, D Mata-Marín, ... Brain 143 (11), 3408-3421, 2020 | 49 | 2020 |
Focused ultrasound for opening blood-brain barrier and drug delivery monitored with positron emission tomography WM Arif, PH Elsinga, C Gasca-Salas, M Versluis, R Martínez-Fernández, ... Journal of controlled release 324, 303-316, 2020 | 49 | 2020 |
Cognitive and psychiatric symptoms in genetically determined Parkinson’s disease: a systematic review R Piredda, P Desmarais, M Masellis, C Gasca‐Salas European journal of neurology 27 (2), 229-234, 2020 | 43 | 2020 |
Neurologic diagnostic criteria for functional neurologic disorders C Gasca-Salas, AE Lang Handbook of clinical neurology 139, 193-212, 2016 | 43 | 2016 |
Striatal blood–brain barrier opening in Parkinson's disease dementia: a pilot exploratory study JA Pineda‐Pardo, C Gasca‐Salas, B Fernández‐Rodríguez, ... Movement Disorders 37 (10), 2057-2065, 2022 | 31 | 2022 |
Parkinson’s disease with mild cognitive impairment: severe cortical thinning antedates dementia C Gasca-Salas, D García-Lorenzo, D Garcia-Garcia, P Clavero, JA Obeso, ... Brain Imaging and Behavior 13, 180-188, 2019 | 28 | 2019 |
Characterization of movement disorder phenomenology in genetically proven, familial frontotemporal lobar degeneration: a systematic review and meta-analysis C Gasca-Salas, M Masellis, E Khoo, BB Shah, D Fisman, AE Lang, ... PLoS One 11 (4), e0153852, 2016 | 27 | 2016 |
Investigating voice as a biomarker for leucine-rich repeat kinase 2-associated Parkinson’s disease S Arora, NP Visanji, TA Mestre, A Tsanas, A AlDakheel, BS Connolly, ... Journal of Parkinson's disease 8 (4), 503-510, 2018 | 26 | 2018 |